PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Whom to Treat?
OncLive,
PARP inhibitors have emerged as agents that generate improved oncological outcomes in select patient populations with…
PARP inhibitors have emerged as agents that generate improved oncological outcomes in select patient populations with…
Greetings! In like a... bear, out like a bull? Data me please! As we wait for the much anticipated (and highly strenuous) data…